How do you assess the return on a therapeutic virtual reality investment?

Beyond the equipment cost, return is measured in real use and the value it generates: patient experience, reduced reliance on pharmacological approaches where clinically appropriate, and time or tension saved for the team in difficult moments. A heavily used tool generates more value than an expensive but forgotten one.

Is the cost only the equipment price?

No. The total cost also includes usage logistics, maintenance, hygiene, and team training. So simplicity of operation and management is part of the calculation: the lower the friction, the lower the real cost of keeping the solution running.

How do you avoid the equipment becoming a cost with no return?

The biggest risk is underuse — equipment bought and then forgotten. Return depends on adoption: tools that are simple to operate, integrated into the workflow, and easy to maintain are the ones that actually get used and generate value.

Cost and ROI

What it costs and what it returns: the ROI of therapeutic virtual reality in a healthcare institution

Assessing the investment in therapeutic virtual reality is not just looking at the equipment price. It is asking how much value it generates each time it is used.

6 min read By RVer

When a healthcare institution considers adopting therapeutic virtual reality, the first question is usually "how much does it cost?". It is the wrong question to start with — or at least an incomplete one. The equipment price is the easiest and most visible part of the sum. What decides real value is something else: how much it is used and how much it generates each time.

Cost is not just price

The total cost of a solution goes beyond the label. It includes:

Usage logistics — where it lives, who prepares it, how it moves around.
Maintenance and hygiene — cleaning routines and the time they consume.
Team training — how much effort until it is operational.

The greater the friction at each of these points, the higher the real cost of keeping the solution alive. So simplicity of operation is not just comfort — it is direct economy.

Return is measured in use

An uncomfortable truth in healthcare: much expensive equipment ends up forgotten in a cupboard. That is the worst ROI scenario — all the cost, no return. The value of a tool is proportional to how often it is actually used.

Cheap, heavily used equipment generates more value than an expensive one no one touches. Adoption is the variable that weighs most on return.

Where the value is

The return of therapeutic VR does not appear on a single budget line. It is spread across several:

Patient experience — difficult moments made more tolerable, with an impact on the perceived quality of the service.
Non-pharmacological approach — a complementary alternative in situations where, clinically, it makes sense to reduce reliance on drugs.
Load avoided for the team — a calmer patient means easier procedures and less tension at the bedside.

Important note: therapeutic virtual reality is a complementary approach, used under the supervision of healthcare professionals and integrated into the care plan. Any clinical decision — including reducing pharmacological approaches — always rests with the healthcare team, not with the technology.

The role of RVer

RVer is an immersive virtual reality therapy system designed for healthcare environments and certified as a Class I Medical Device by Infarmed, in compliance with the European regulation MDR 2017/745. It is built to lower the friction that kills ROI: simple for teams to operate and manage, comfortable for the patient, and with no collection of patient clinical data.

The best return in healthcare comes from the tools the team can actually use every day — not the ones that sit in storage losing value.

Want to learn about RVer?

See how certified therapeutic virtual reality fits into your service.

Explore RVer

← Back to the blog